A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT01458340 · COMPLETED
Trial details
- NCT number
- NCT01458340
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-10-01
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.